{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "Not specified",
        "Protein_Change": {
          "ref": "A",
          "alt": "P",
          "position": "30"
        },
        "variant_string_id": "A30P"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Our A30P results, in conjunction with previous studies that demonstrated a reduced affinity of the A30P mutant for membranes in vivo [13,29] and in vitro, [30] provide additional support for the hypothesis that the F-state extends",
          "judgment": "Yes",
          "reasoning": "The paper clearly states that the A30P mutation is associated with reduced affinity for membranes, which supports the hypothesis about the F-state conformational changes. This indicates a defined disease mechanism related to protein conformation and membrane affinity."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "Two-dimensional contour plot of the raw data presented in (c). U, I, and F are different protein conformational states that exhibit characteristic FRET efficiency and helicity.",
          "judgment": "Yes",
          "reasoning": "The paper uses single-molecule FRET (smFRET) to analyze protein conformational states (U, I, F), which is a valid and applicable assay class for studying protein conformational changes associated with the A30P mutation. This method directly relates to the disease mechanism described.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3a: Basic Controls and Replicates",
          "extracted_paper_info": "Two-dimensional contour plot of previously reported WT data for comparison with the corresponding plot for the A30P mutant.",
          "judgment": "Yes",
          "reasoning": "The paper includes wild-type (WT) data as a control for comparison with the A30P mutant, indicating the presence of both normal/negative (WT) and abnormal/positive (A30P) controls. This suggests that basic controls were included.",
          "next_step_or_outcome": "Proceed to Step 3c"
        },
        {
          "step_name": "Step 3c: Variant Controls",
          "extracted_paper_info": "Two-dimensional contour plot of previously reported WT data for comparison with the corresponding plot for the A30P mutant.",
          "judgment": "No",
          "reasoning": "The paper only compares the A30P mutant with wild-type (WT) data and does not mention the use of known pathogenic or benign variants as controls. Therefore, variant controls were not used in the assay.",
          "next_step_or_outcome": "Proceed to Step 4b"
        },
        {
          "step_name": "Step 4b: No OddsPath Calculation",
          "extracted_paper_info": "Not explicitly mentioned",
          "judgment": "No",
          "reasoning": "The paper does not provide a specific number of benign or pathogenic variant controls used in the study, making it unclear whether 10 or fewer were used.",
          "next_step_or_outcome": "Proceed to Step 4c"
        },
        {
          "step_name": "Step 4c: Correlate OddsPath",
          "extracted_paper_info": "Not explicitly mentioned",
          "judgment": "No",
          "reasoning": "The paper does not provide any OddsPath value or robust statistical analysis for the A30P variant, making it impossible to determine the strength of the functional evidence based on OddsPath.",
          "next_step_or_outcome": "N/A"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      },
      "overall_conclusion": "The A30P variant shows reduced affinity for membranes and conformational changes, supported by smFRET analysis. However, the lack of variant controls and statistical analysis limits the strength of the evidence to PS3_supporting."
    }
  ]
}